Analysen von Dani Saurymper
| 13.02.15 | GSK overweight | Barclays Capital | |
| 10.02.15 | AstraZeneca verkaufen | Barclays Capital | |
| 17.11.14 | AstraZeneca neutral | Barclays Capital |
| 13.02.15 | GSK overweight | Barclays Capital | |
| 10.02.15 | AstraZeneca verkaufen | Barclays Capital | |
| 17.11.14 | AstraZeneca neutral | Barclays Capital |